Mechanistic impasses: tofacitinib treatment ameliorates GM-CSF-driven macrophage inflammation

Cellular and Molecular Immunology · Published 2026-03-23 · DOI 10.1038/s41423-026-01406-x

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1038/s41423-026-01406-x

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Macrophage CCRL2 promotes NLRP3 inflammasome activation to exacerbate atherosclerosis · Cellular and Molecular Immunology · 2026 · Same journal
• Melanosomes support immune evasion in melanoma · Cellular and Molecular Immunology · 2026 · Same journal
• T cell adaptation in chronic infections and tumors · Cellular and Molecular Immunology · 2026 · Same journal
• Cathepsin C orchestrates RSV-induced asthma exacerbation through the dual effect of monocyte-derived macrophages · Cellular and Molecular Immunology · 2026 · Same journal
• Lytic IFNγ is stored in cytotoxic granules and coreleased with granzyme B to mediate cytotoxic T lymphocyte killing · Cellular and Molecular Immunology · 2026 · Same journal
• Defining the rules of engagement: B cells, antibodies and cancer control · Cellular and Molecular Immunology · 2026 · Same journal
• Vimentin trogocytosis as a novel mechanism of NK cell exhaustion by circulating tumor cells · Cellular and Molecular Immunology · 2026 · Same journal
• TWEAK receptor (Fn14) exacerbates TNF-α-induced inflammation in rheumatoid arthritis synovial fibroblasts and influences response to anti-TNF-α therapy · Cellular and Molecular Immunology · 2026 · Same journal
• The Parkinson’s disease-linked G2019S mutation of LRRK2 increases NADPH oxidase-2 activity in neutrophils for superior control of bacterial infections · Cellular and Molecular Immunology · 2026 · Same journal
• Mapping the holonomic signaling network that drives pathological changes in endotoxic shock · Cellular and Molecular Immunology · 2026 · Same journal